| 期刊論文 |
|
|
|
       
|
期刊論文: (*Corresponding author) 1. Chang YC, Yang SF, Hsieh YS.* Regulation of matrix metalloproteinase-2 production by cytokines and pharmacological agents in human pulp cell cultures. Journal of Endodontics 2001; 27: 679-682. (SCI) 2. Chiang WL, Chu SC, Lai JC, Yang SF, Chiou HL, Hsieh YS.* Alternations in quantities and activities of erythrocyte cytosolic carbonic anhydrase isoenzymes in glucose-6-phosphate dehydrogenase deficiency individuals. Clinica Chimica Acta 2001; 314: 195-201. (SCI) 3. Chang YC, Lai CC, Yang SF, Chan Y, Hsieh YS.* timulation of matrix metalloproteinase by black-pigmented Bacteroides in human pulp and periodontal ligament cells cultures. Journal of Endodontics 2002; 28: 90-93. (SCI) 4. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS.* Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncology 2002; 38: 195-200. (SCI) 5. Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS.* Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. Journal of Periodontal Research 2002; 37: 196-203. (SCI) 6. Chou FP, Chu SC, Cheng MC, Yang SF, Cheung WN, Chiou HL, Hsieh YS.* (2002) Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clinical Biochemistry 2002; 35: 383-388. (SCI) 7. Chiang WL, Chu SC, Yang SS, Li MC, Lai JC, Yang SF, Chiou HL, Hsieh YS.* The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. Cancer Letters 2002; 188: 199-205. (SCI) 8. Kuo WH, Yang SF, Chu SC, Lu SO, Chou FP,* Hsieh YS.* Differential inductions of matrix metalloproteinase-2 and -9 in host tissues during the growth of ascitic sarcoma 180 cells in mice. Cancer Letters 2003; 189: 103-112. (SCI) 9. Chang YC, Yang SF, Huang FM, Tai KW, Hsieh YS.* Induction of tissue plasminogen activator gene expression by proinflammatory cytokines in human pulp and gingival fibroblasts. Journal of Endodontics 2003; 29: 114-117. (SCI) 10. Chang YC, Yang SF, Huang FM, Liu CM, Tai KW, Hsieh YS.* Proinflammatory cytokines induce cyclooxygenase-2 mRNA and protein expression in human pulp cell cultures. Journal of Endodontics 2003; 29: 201-204. (SCI) 11. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC.* The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncology 2003; 39: 367-372. (SCI) 12. Chang YC, Huang FM, Yang SF, Liu CM, Lai CC, Chan Y, Hsieh YS.* Induction of cyclooxygenase-2 mRNA and protein expression in human pulp cells stimulated with black-pigmented bacteroides. Journal of Endodontics 2003; 29: 240-243. (SCI) 13. Yang SF, Hsieh YS, Huang FM, Yang LC, Chang YC.* Effect of black-pigmented bacteria on the plasminogen-plasmin system in human pulp and osteoblastic cells. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2003; 95: 621-625. (SCI) 14. Tsai CH, Hsieh YS, Yang SF, Chou MY, Chang YC.* Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2003; 95: 710-716. (SCI) 15. Kuo WH, Chiang WL, Yang SF, Yeh KT, Yeh CM, Hsieh YS, Chu SC.* The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma. Life Science 2003; 73: 2211-2223. (SCI) 16. Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH. * The clinical significance of gelatinase B in gouty arthritis of the knee. Clinica Chimica Acta 2004; 339: 77-83. (SCI) 17. Lu KH, Yang SF, Chu SC, Chen PN, Chou MC, Hsiao TY, Hsieh YS.* The significance of altered gelatinase expression in the synovium of patient with arthritic effusions. Clinical Rheumatology 2004; 23: 21-26. (SCI) 18. Chu SC, Wang CP, Chang YH, Hsieh YS, Yang SF, Su JM, Yang CC, Chiou HL.* Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clinica Chimica Acta 2004; 341: 133-138. (SCI) 19. Huang FM, Yang SF, Hsieh YS, Liu CM, Yang LC, Chang YC.* Examination of the signal transduction pathways involved in matrix metalloproteinases-2 in human pulp cells. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2004; 93: 398-403. (SCI) 20. Chang YC, Chu SC, Yang SF, Hsieh YS, Yang LC, Huang FM.* Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1alpha and Porphyromonas gingivalis in human osteosarcoma cells. Journal of Periodontal Research 2004; 39:168-174. (SCI) 21. Hsieh YS, Yang SF, Chu SC, Chen PN, Chou MC, Hsu MC, Lu KH.* Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement. Arthroscopy 2004; 20: 482-488. (SCI) 22. Chu SC, Chiou HL, Chen PN, Yang SF, Hsieh YS.* Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Molecular carcinogenesis 2004; 40: 143-149. (SCI) 23. Chu SC, Tsai CH, Yang SF, Huang FM, Su YF, Hsieh YS, Chang YC.* Induction of vascular endothelial growth factor gene expression by proinflammatory cytokines in human pulp and gingival fibroblasts. Journal of Endodontics 2004; 30: 704-707. (SCI) 24. Chiang WL, Liu JY, Liao CY, Yang SF, Hsieh YS, Chu SC.* Alternation of cytosolic carbonic anhydrase isoenzymes during deciduomatal development in pregnant mice. Fertility and Sterility 2004; 82 Suppl 3: 1095-1100. (SCI) 25. Chu SC, Yang SF, Lue KH, Hsieh YS, Wu CL, Lu KH.* Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee. Connective Tissue Research 2004; 45: 142-150. (SCI) 26. Tsai CH, Yang SF, Chen YJ, Chu SC, Hsieh YS, Chang YC.* Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels. Oral Disease 2004; 10: 360-364. (SCI) 27. Chu SC, Hu DN,* Yang SF, Yang PY, Hsieh YS, Huang SM, Yu G, McCormick SA. Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro. Pigment Cell Research 2004; 17: 636-642. (SCI) 28. Chu SC, Yang SF, Lue KH, Hsieh YS, Lin ZI, Lu KH.* Clinical significance of gelatinases in septic arthritis of native and replaced knees. Clinical Orthopaedics and Related Research 2004; 427: 179-183. (SCI) 29. Hsieh YS, Hsu JD, Yang SF, Kuo DY.* Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression. Peptides 2004; 25: 2155-2161. 30. Kuo WH, Yang SF, Hsieh YS, Tsai CS, Hwang WL, Chu SC.* Differential expression of carbonic anhydrase isoenzymes in various types of anemia. Clinica Chimica Acta 2005; 351: 79-86. (SCI) 31. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC.* Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro. Journal of Oral Pathology Medicine 2005; 34: 100-105. 32. Yang SF, Chu SC, Chiang IC, Kuo WF, Chiou HL, Chou FP, Kuo WH, Hsieh YS.* Excessive matrix metalloproteinase-9 in the plasma of community- acquired pneumonia. Clinica Chimica Acta 2005; 352: 209-215. (SCI) 33. Hsieh YS, Yang SF, Kuo DY.* Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. Regulatory Peptides 2005; 127: 169-176. (SCI) 34. Weng MW, Hsiao YM, Chiou HL, Yang SF, Hsieh YS, Cheng YW, Yang CH, Ko JL.* Alleviation of benzo[a]pyrene-diolepoxide-DNA damage in human lung carcinoma by glutathione S-transferase M2. DNA Repair 2005; 4: 493-502. (SCI) 35. Yang SF, Hsieh YS, Lin CL, Hsu NY, Chiou HL, Chou FP, Chu SC.* Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. Clinica Chimica Acta 2005; 354: 91-99. (SCI) 36. Chang YC, Huang HP, Hsu JD, Yang SF, Wang CJ.* Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells. Toxicology and Applied Pharmacology 2005; 205: 201-212. (SCI) 37. Chen TY, Hsieh YS, Yang CC, Wang CP, Yang SF, Cheng YW, Chiou HL.* Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease. Clinical Biochemistry 2005; 38: 632-638. (SCI) 38. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC.* The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncology 2005; 41: 940-946. (SCI) 39. Hsieh YS, Yang SF, Chiou HL, Kuo DY.* Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression. European Journal of Neuroscience 2005; 22: 715-723. (SCI) 40. Huang FM, Tsai CH, Yang SF, Chang YC.* Induction of Interleukin-6 and Interleukin-8 gene expression by root canal sealers in human osteoblastic cells. Journal of Endodontics 2005; 31: 679-683. (SCI) 41. Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF, Hsieh YS.* Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppresses tumor growth in vivo. Nutrition and Cancer 2005; 53: 232-243. (SCI) 42. Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH.* Urokinase-type plasminogen activator, receptor and inhibitor correlating with gelatinase-B (MMP-9) contributes to the inflammation in gouty arthritis of the knee. Journal of Rheumatology 2006; 33: 311-317. (SCI) 43. Chen PN, Hsieh YS, Chiang C L, Chiou HL, Yang SF, Chu SC.* Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. Journal of Dental Research 2006; 85: 220-225. (SCI) 44. Chang HR, Yang SF, Li ML, Lin CC, Hsieh YS*, Lian JD.* Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease. Clinica Chimica Acta 2006; 366: 243-248. Contributed equally as first author (SCI) 45. Hsieh YS, Yang SF, Chiou HL, Kuo DY.* Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Toxicology and Applied Pharmacology 2006; 212: 99-109. (SCI) 46. Hsieh YS, Yang SF, Lue KH, Lu KH.* Clinical significance of the PA/plasmin system in septic arthritis of the knee. Clinical Orthopaedics and Related Research 2006; 447: 172-178. (SCI) 47. Liu SC, Yang SF, Yeh KT, Yeh CM, Chiou HL, Lee CY, Chou MC,* Hsieh YS.* Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clinica Chimica Acta 2006; 371: 92-96. (SCI) 48. Chu SC, Yang SF, Lue KH, Hsieh YS, Lee CY, Chou MC, Lu KH.* Glucosamine sulphate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis Clinica Chimica Acta 2006; 372: 167-172. (SCI) 49. Su SC, Hua KF, Lee H, Chao LK, Tan SK, Lee H, Yang SF,* Hsu HY.* LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. Clinica Chimica Acta 2006; 374: 106-115. (SCI) 50. Chiang WL, Hsieh YS, Yang SF, Lu TA, Chu SC.* Differential expression of Glutathione-S-Transferase isoenzymes in various types of anemia in Taiwan. Clinica Chimica Acta 2007; 375: 110-114. (SCI) 51. Yang SF, Hsieh YS, Tsai CH, Chen YJ, Chang YC.* Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Disease 2007; 13: 234-238. (SCI) 52. Hsieh YS, Yang SF, Kuo DY.* Intracerebral administration of protein kinase A (PKA) or c-AMP response element binding protein (CREB) antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free moving rats. American Journal of Physiology. Endocrinology and Metabolism 2007; 292: E123-E131. (SCI) 53. Hsiao YC, Hsieh YS, Kuo WH, Chiou HL, Yang SF, Chiang WL, Chu SC.* The tumor-growth inhibitory activity of flavanone and 2’-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. Journal of Biomedical Science 2007; 14: 107-119. (SCI) 54. Yang SF, Chu SC, Liu SJ, Chen YC, Chang YZ, Hsieh YS.* Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo. Journal of Ethnopharmacology 2007; 110; 483-489. (SCI) 55. Hsieh YS, Chu SC, Yang SF, Chen PN, Liu YC, Lu KH.* Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis 2007; 285: 977-987. (SCI) 56. Hsieh YS, Yang SF, Lue KH, Chu SC, Lu KH.* Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinases expression via three MAPKs and PI3K pathways during the early development of osteoarthritis. Journal of Rheumatology 2007; 34: 785-793. (SCI) 57. Chu SC, Yang SF, Liu SJ, Kuo WH, Chang YZ, Hsieh YS.* In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells. Food and Chemical Toxicology 2007; 45: 1194-1201. Contributed equally as first author (SCI) 58. Ne WF, Tsai CH, Yang SF, Chang YC. * Elevated expression of NF-kappaB in oral submucous fibrosis - Evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. Oral Oncology 2007; 46: 557-562. (SCI) 59. Hsu CG, Wang PH, Ko JL, Chen GD, Chang H, Yang SF, Chen SC, Lin LY.* Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix International Journal of Gynecological Cancer 2007; 17: 851-857. (SCI) 60. Tsai CH, Yang SF, Chang YC.* The upregulation of cystatin C in oral submucous fibrosis. Oral Oncology 2007; 43: 680-685. (SCI) 61. Lai TJ, Hsu SF, Li TM, Hsu HC, LinJG, Hsu CJ, Chou MC, Lee MC, Yang SF, Fong YC.* Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line. Acta Pharmacologica Sinica. 2007; 28: 1231-1235. (SCI) 62. Wang PH, Chen GD, Chang H, Yang SF, Han CP, Lin LY, * Ko JL.* High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection. Reproductive Science 2007; 14: 338-348. (SCI) 63. Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, Chiou HL.* The impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Translational Research 2007; 150: 116-121. (SCI) 64. Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS,* Kuo WH.* Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Archives of Toxicology 2007; 81: 719-728. (SCI) 65. Hsieh YS, Yang SF, Chiou HL, Kuo DY.* Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Behavioral Neuroscience 2007; 121: 933-940. (SCI) 66. Hsieh YS, Lee YL, Yang SF, Chen LY, Yang JS, Chen SC, Shih CM.* Association of EcoRI polymorphism of the metastasis-suppressor Gene NME1 with susceptibility to and severity of non-small cell lung cancer. Lung cancer 2007; 58: 191-195. (SCI) 67. Wang PH, Yang SF, Chen GD, Han CP, Chen SC, Lin LY,* Ko JL.* Human nonmetastatic clone 23 type 1 gene suppresses migration of cervical cancer cells and enhances the migration inhibition of fungal immunomodulatory protein from Ganoderma Tsugae. Reproductive Science 2007; 14: 475-485. (SCI) 68. Yang SF,* Wang PH, Lin LY, Ko JL, Chen GD, Yang JS, Hsieh YS.* A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of uterine cervix. Reproductive Science 2007; 14: 710-718. (SCI) 69. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC.* Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator Journal of Oral Pathology Medicine 2007; 36: 588-593. (SCI) 70. Hsieh YS, Yang SF, Chu SC, Kuo DY.* Transcript of protein kinase A knock down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats. Physiological Genomics 2007; 31: 306-314. (SCI) 71. Tee YT, Han CP, Ko JL, Chen GD, Yang SF, Chen SC, Tsai HJ, Lin LY,* Wang PH.* Evaluation of matrix metalloproteinase-2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity. Reproductive Science 2007; 14: 719-726. (SCI) 72. Hsieh YS, Yang SF, Chu SC, Kuo DY.* Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine. Journal of Neurochemistry 2008; 104: 50-61. (SCI) 73. Yang SF, Hsieh YS, Lue KH, Chu SC, Chang IC, Lu KH.* Effects of nonsteroidal antiinflammatory drugs on expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans. Clinical Biochemistry 2008; 41: 109-116. (SCI) 74. Chu SC, Yang SF, Lue KH, Hsieh YS, Chang IC, Lu KH.* Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis. Clinica Chimica Acta 2008; 387: 90-96. (SCI) 75. Weng CJ, Chau CF, Hsieh YS, Yang SF, Yen GC.* Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kB and AP-1. Carcinogenesis 2008; 29: 147-156. (SCI) 76. Lee SS, Yang SF, Ho YC, Tsai CH, Chang YC.* The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Oncology 2008; 44: 180-186. (SCI) 77. Hsieh YS, Yang SF, Lue KH, Chu SC, Lu KH.* Effects of different molecular weight hyaluronan products on the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis. Journal of Orthopedic Research 2008; 26: 475-484. (SCI) 78. Yang SF, Yang WE, Kuo WH, Chang HR, Chu SC, Hsieh YS.* Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Archive of Oral Biology 2008; 53: 287-294. (SCI) 79. Chang HR, Kuo WH, Hsieh YS, Yang SF, Li ML, Lin CC, Lian JD,* Chu SC.* Circulating matrix metalloproteinase-2 is associated with cystatin C level, post-transplant duration, and diabetes mellitus in kidney transplant recipients. Translational Research 2008; 151: 217-223. (SCI) 80. Yang SF, Tsai CH, Chang YC.* The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline. Journal of Oral Pathology Medicine 2008; 37: 206-210. (SCI) 81. Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY,* Chen GD.* Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array. Gynecologic Oncology 2008; 108: 533-542. (SCI) 82. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS.* Luteolin induces apoptosis in oral squamous cancer cells. Journal of Dental Research 2008; 87: 401-406. (SCI) 83. Hsieh YS, Yang SF, Chu SC, Ho YJ, Kuo CS, Kuo DY.* Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats. Journal of Neurochemistry 2008; 105: 1438-1449. (SCI) 84. Huang FM, Yang SF, Chang YC.* Up-regulation of gelatinases and tissue type plasminogen activator by root canal sealers in human osteoblastic cells. Journal of Endodontics 2008; 34: 291-294. (SCI) 85. Lee SS, Yang SF, Tsai CH, Chou MC, Chou MY, Chang YC.* Upregulation of Heme Oxygenase-1 Expression in Areca-quid-chewing-associated Oral Squamous Cell Carcinoma. Journal of the Formosan Medical Association 2008; 107: 355-363. (SCI) 86. Lee SA, Tsai HT, Ou HC, Han CP, Tee YT, Chen YC, Wu MT, Chou MC, Wang PH*, Yang SF.* Serum interleukin-1b, -6, -8, and tumor necrosis factor alpha as highly informative markers of pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine 2008; 46: 997-1003. (SCI) 87. Hsu CG, Lin LY, Ko JL, Yang SF, Chang H, Lin CY, Tsai HT, Chen SC, Chen SC, Wang PH.* High expression of human nonmetastatic clone 23 type 1 in cancer of uterine cervix and its association with poor cell differentiation and worse overall survival. Journal of Surgical Oncology 2008; 98: 448-456. (SCI) 88. Chen KS, Wang PH, Yang SF, Lin DB, Lin YJ, Kuo DY, Lin LY, Wu MT, Lin CW, Lee S, Chou MC, Tsai HT,* Hsieh YS.* Significant elevation of a Th2 cytokine, interleukin-10, in pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine 2008; 46: 1609-1016. (SCI) 89. Tee YT, Wang PH, Yang SF, Ng SC, Ko JL, Chen GD, Chang H, Lin LY*. Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer. The Journal of Obstetrics and Gynaecology Research 2008; 34: 1002-9. (SCI) 90. Tsai HT, Wang PH, Tee YT, Lin LY, Hsieh YS,* Yang SF.* Imbalance serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease. Fertility and Sterility 2009; 91: 549-55. (SCI) 91. Wang PH, Tsai HT, Tee YT, Lin LY, Yang SF,* Hsieh YS.* Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproeinase-2 in patients with pelvic inflammatory disease. Fertility and Sterility 2009; (In press) (SCI) 92. Tzang BS, Yang SF, Fu SG, Yang HC, Sun HL, Chen YC*. Effects of dietary flaxseed oil on cholesterol metabolism of hamsters. Food Chemistry 2009; (In press) (SCI) 93. Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF,* Wong RH.* Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis. Annals of the Rheumatic Diseases 2009; (In press) (SCI) 94. Lee SA, Wang PH, Chiou HL, Chou MC, Tsai HT,* Yang SF.* Markedly elevated plasma myeloperoxidase protein in patients with A allele myeloperoxidase gene polymorphism in patients with pelvic inflammatory disease. Fertility and Sterility 2009; (In press) (SCI) 95. Ho YC, Yang SF, Huang FM, Chang YC.* The upregulation of osteolytic mediators in human osteosarcoma cells stimulated with nicotine. Journal of Periodontal Research 2009; (In press) (SCI) 96. Kuo DY, Yang SF, Chu SC, Chen CH, Hsieh YS.* Roles of protein kinase Cα isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression. Journal of Neurochemistry 2009; (In press) (SCI) 97. Chang HR, Yang SF, Lian JD, Lin CC, Wen MC, Chen YT, Jan YJ, Hsieh YS.* Prediction of chronic allograft damage index of renal allografts using serum level of plasminogen activator inhibitor-1. Clinical Transplantation 2009; (In press) (SCI) 98. Tsai CH, Yang SF, Huang FM, Chang YC.* The upregulation of cystatin c in human gingival fibroblasts stimulated with cyclosporine A. Journal of Periodontal Research 2009; (In press) (SCI) 99. Ho YC, Yang SF, Huang FM, Chang YC.* Up-regulation of osteolytic mediators in human osteosarcoma cells stimulated with nicotine. Journal of Periodontal Research 2009; (In press) (SCI) 100. Teng YH, Liu TH, Tseng HC, Chung TT, Yeh CM, Li YC, Ou YH, Lin LY, Tsai HT,* Yang SF.* The contribution of genetic polymorphisms of Stromal Cell- Derived Factor-1 and Its Receptor, CXCR4, to the Susceptibility and Clinicopathological Development of Oral Cancer. Head & Neck 2009; (In press) (SCI) 101. Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, Ma HJ, Chou MC, Tsai HT*, Yang SF*. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clinical Chemistry and Laboratory Medicine 2009; (In press) (SCI) 102. Tsai HT, Tee YT, Chiou HL, Hsieh YH, Lin CW, Tsai HC, Wang PH*, Yang SF*. Elevated plasma stromal cell-derived factor-1 protein and its gene polymorphism in patients with pelvic inflammatory disease. Reproductive Science 2009; (In press) (SCI) 103. Teng YH, Tsai HT, Hsieh YS, Chen YC, Lin CW, Lee MC, Lin LY*, Yang SF*. Elevated erythrocyte carbonic anhydrase activity is a novel clinical marker in hyperventilation syndrome. Clinical Chemistry and Laboratory Medicine 2009; (In press) (SCI) 104. Tsai CH, Yang SF, Lee SS, Chang YC.* Augmented heme oxygenase-1 expression in areca quid chewing associated-oral submucous fibrosis. Oral Diseases 2009; (In press) (SCI)
上次修改此網站的日期： 2009年02月10日 |
